Therapeutic ProgramsOn the move
 | ||
 Motexafin Gadolinium | ||
| Brain Metastases |  | |
| Glioblastoma |  | |
| Pediatric glioma | | |
| HDAC Inhibitors | ||
| Hematologic tumors | | |
| Solid and hematopoietic tumors |  | |
| Factor VIIa Inhibitor |
||
| Cancer | | |
| Tyrosine Kinase Inhibitors | ||
| Lymphomas |  | |
| Autoimmune disorders | | |